Check-Cap Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011336851
USD
1.75
0.09 (5.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

90.91 k

Shareholding (Dec 2023)

FII

7.29%

Held by 53 FIIs

DII

92.6%

Held by 0 DIIs

Promoter

0.11%

How big is Check-Cap Ltd.?

22-Jun-2025

As of Jun 18, Check-Cap Ltd. has a market capitalization of 4.49 million, categorizing it as a Micro Cap company, with total assets of 25.02 million and shareholder's funds of 23.69 million.

Market Cap: As of Jun 18, Check-Cap Ltd. has a market capitalization of 4.49 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Check-Cap Ltd. reported net sales of 0.00 million and a consolidated net profit of -17.57 million.<BR><BR>Balance Sheet Snapshot: As of Dec'23, the company has shareholder's funds amounting to 23.69 million and total assets of 25.02 million.

Read More

What does Check-Cap Ltd. do?

22-Jun-2025

Check-Cap Ltd. is an Israeli clinical-stage medical diagnostics company developing an ingestible imaging system for colorectal cancer screening. It has a market cap of $4.49 million and reported a net loss of $4 million in December 2023.

Overview: <BR>Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Israel, developing a capsule-based system for ingestible imaging aimed at colorectal cancer screening, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -4 Million (Quarterly Results - Dec 2023) <BR>Market Cap: USD 4.49 Million (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.05 <BR>Return on Equity: -68.15% <BR>Price to Book: 0.19 <BR><BR>Contact Details: <BR>Address: 29 Abba Hushi Ave., Isfiya, P.O.Box 1271 None: 3009000 <BR>Tel: ['972 4 8303401', '1 212 9152568'] <BR>Fax: 972 4 8211267 <BR>Website: http://www.check-cap.com

Read More

Who are in the management team of Check-Cap Ltd.?

22-Jun-2025

As of March 2022, the management team of Check-Cap Ltd. includes Mr. Steven Hanley (Chairman), Mr. XiangQian Lin (Director), and independent directors Ms. Clara Ezed, Dr. Mary Jo Gorman, and Mr. Yuval Yanai.

As of March 2022, the management team of Check-Cap Ltd. includes the following individuals:<BR><BR>- Mr. Steven Hanley, Chairman of the Board<BR>- Mr. XiangQian Lin, Director<BR>- Ms. Clara Ezed, Independent Director<BR>- Dr. Mary Jo Gorman, Independent Director<BR>- Mr. Yuval Yanai, Independent Director

Read More

Is Check-Cap Ltd. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Check-Cap Ltd. is in a mildly bearish trend despite recent strong short-term returns, with mixed technical indicators showing bullish momentum but bearish price strength.

As of 10 September 2025, the technical trend for Check-Cap Ltd. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The weekly MACD is bullish, while the monthly MACD is mildly bullish, suggesting some positive momentum. However, the weekly and monthly RSI readings are bearish, indicating weakness in price strength. The daily moving averages are mildly bearish, which adds to the cautious outlook. <BR><BR>In terms of returns, Check-Cap has significantly outperformed the S&P 500 over the past week and month, with returns of 265.89% and 279.73% respectively, but it has underperformed over longer periods, including a 3-year return of -59.52% compared to the S&P 500's 70.41%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 4 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.05

stock-summary
Return on Equity

-68.15%

stock-summary
Price to Book

0.17

Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2023)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
159.26%
0%
159.26%
6 Months
118.75%
0%
118.75%
1 Year
117.93%
0%
117.93%
2 Years
-39.02%
0%
-39.02%
3 Years
-53.95%
0%
-53.95%
4 Years
-87.97%
0%
-87.97%
5 Years
-76.22%
0%
-76.22%

Check-Cap Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-31.65%
EBIT to Interest (avg)
-16.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.05
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.29%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.20
EV to EBIT
1.12
EV to EBITDA
1.14
EV to Capital Employed
18.77
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1670.81%
ROE (Latest)
-68.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 53 Foreign Institutions (7.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Check-Cap Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 7.85% vs -11.05% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.60",
          "val2": "-19.60",
          "chgp": "10.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.40",
          "val2": "-0.10",
          "chgp": "-1,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.60",
          "val2": "-19.10",
          "chgp": "7.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-17.60
-19.60
10.20%
Interest
0.00
0.00
Exceptional Items
-1.40
-0.10
-1,300.00%
Consolidate Net Profit
-17.60
-19.10
7.85%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 7.85% vs -11.05% in Dec 2022

stock-summaryCompany CV
About Check-Cap Ltd. stock-summary
stock-summary
Check-Cap Ltd.
Pharmaceuticals & Biotechnology
Check-Cap is a Israel-based clinical-stage medical diagnostics company developing. The Company develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
Company Coordinates stock-summary
Company Details
29 Abba Hushi Ave., Isfiya, P.O.Box 1271 None : 3009000
stock-summary
Tel: 972 4 83034011 212 9152568
stock-summary
Registrar Details